2020. Early and Maintained Response Levels in Psoriasis Patients Treated with Tildrakizumab. SKIN The Journal of Cutaneous Medicine. 4, 5 (Sep. 2020), s41. DOI:https://doi.org/10.25251/skin.4.supp.41.